[PDF][PDF] Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular‐cholangiocarcinoma

X Cai, J Zhai, DE Kaplan, Y Zhang, L Zhou… - …, 2012 - Wiley Online Library
Hepatic progenitor cells (HPC) play important roles in both liver regeneration and
carcinogenesis. Combined hepatocellular‐cholangiocarcinoma (CHC), a malignant primary …

Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International …

AD Burt, V Alves, P Bedossa, A Clouston… - …, 2018 - Wiley Online Library
Optimal patient management benefits from comprehensive and accurate pathology reports
that contribute to cancer staging and prognostication. Proforma reports are used in many …

[HTML][HTML] Imaging of HCC—current state of the art

C Schraml, S Kaufmann, H Rempp, R Syha, D Ketelsen… - Diagnostics, 2015 - mdpi.com
Early diagnosis of hepatocellular carcinoma (HCC) is crucial for optimizing treatment
outcome. Ongoing advances are being made in imaging of HCC regarding detection …

Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications

JY Choi, HC Cho, M Sun, HC Kim… - American Journal of …, 2013 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to retrospectively evaluate the imaging
characteristics and outcomes of indeterminate observations (Liver Imaging Reporting and …

Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma

J Rimola, A Forner, V Sapena, N Llarch, A Darnell… - European …, 2020 - Springer
Objective To determine the diagnostic accuracy and predictive value of gadoxetic acid liver
MRI (Gd-EOB-DTPA MRI) alone or in combination with diffusion-weighted imaging (DWI) as …

[HTML][HTML] Brazilian society of hepatology updated recommendations for diagnosis and treatment of hepatocellular carcinoma

AL Chagas, AA MATTOS, FJ Carrilho… - Arquivos de …, 2020 - SciELO Brasil
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality
worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first …

[HTML][HTML] Diagnosis of hepatocellular carcinoma: an update on international guidelines

C Cassinotto, C Aubé, A Dohan - Diagnostic and interventional imaging, 2017 - Elsevier
Imaging is essential for the successful management of patients with or at risk of developing
hepatocellular carcinoma (HCC). If ultrasound remains the key screening modality …

Liver cancer working group report

M Kudo, KH Han, N Kokudo, AL Cheng… - Japanese journal of …, 2010 - academic.oup.com
Hepatocellular carcinoma is a highly prevalent disease in many Asian countries, accounting
for 75–80% of victims worldwide. The incidence of hepatocellular carcinoma varies …

[HTML][HTML] Altered glycosylation associated with dedifferentiation of hepatocellular carcinoma: a lectin microarray-based study

H Takayama, M Ohta, Y Iwashita, H Uchida, Y Shitomi… - BMC cancer, 2020 - Springer
Background Altered glycosylation associated with hepatocellular carcinoma (HCC) is well
documented. However, few reports have investigated the association between …

Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis

SK Kim, H Takeda, A Takai, T Matsumoto… - Journal of …, 2019 - Springer
Background Hepatocellular carcinoma (HCC) recurrently develops in cirrhotic liver
containing a number of regenerative nodules (RNs). However, the biological tumorigenic …